Donor-derived CD19 chimeric antigen receptor T cells

被引：6

作者：

Singh, Nathan ^{[1
]}

Barrett, David M. ^{[2
]}

机构：

[1] Univ Penn, Dept Med, Philadelphia, PA 19104 USA

[2] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA

来源：

CURRENT OPINION IN HEMATOLOGY | 2015年 / 22卷 / 06期

关键词：

chimeric antigen receptors; immunotherapy; T cells; LEUKOCYTE INFUSIONS; HOST-DISEASE; GRAFT; THERAPY; IMMUNOTHERAPY; MALIGNANCIES; TRANSPLANT; EXPRESSION; 4-1BB;

D O I：

10.1097/MOH.0000000000000179

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Purpose of reviewAs immunotherapy matures into possible front-line therapy, new approaches are necessary to expand the capacity to treat more patients. Although most technologies for chimeric antigen receptor (CAR) therapies require autologous T cells, off the shelf' sources are highly desired.Recent findingsSources of T cells for modification with CARs include cord blood and either related or unrelated allogeneic donors. Strategies to manipulate these sources focus on reducing the risk of alloreactivity, while maintaining the potential for high function and long persistence associated with successful CAR T-cell therapies.SummaryRecent research implies that manipulating nonautologous T-cell sources can result in well tolerated and effective products, but work remains to determine if these approaches will reach the efficacy of autologous products.

引用

页码：503 / 508

页数：6

共 34 条

[1] Relation of clinical culture method to T-cell memory status and efficacy in xenograft models of adoptive immunotherapy [J].

Barrett, David M. ;

Singh, Nathan ;

Liu, Xiaojun ;

Jiang, Shuguang ;

June, Carl H. ;

Grupp, Stephan A. ;

Zhao, Yangbing .

CYTOTHERAPY, 2014, 16 (05) :619-630

[2] Chimeric Antigen Receptor Therapy for Cancer [J].

Barrett, David M. ;

Singh, Nathan ;

Porter, David L. ;

Grupp, Stephan A. ;

June, Carl H. .

ANNUAL REVIEW OF MEDICINE, VOL 65, 2014, 65 :333-347

[3] Chimeric antigen receptor-redirected CD45RA-negative T cells have potent antileukemia and pathogen memory response without graft-versus-host activity [J].

Chan, W. K. ;

Suwannasaen, D. ;

Throm, R. E. ;

Li, Y. ;

Eldridge, P. W. ;

Houston, J. ;

Gray, J. T. ;

Pui, C-H ;

Leung, W. .

LEUKEMIA, 2015, 29 (02) :387-395

[4] Transfer of aflogeneic CD62L- memory T cells without graft-versus-host disease [J].

Chen, BJ ;

Cui, XY ;

Sempowski, GD ;

Liu, CX ;

Chao, NJ .

BLOOD, 2004, 103 (04) :1534-1541

[5] Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study [J].

Cruz, Conrad Russell Y. ;

Micklethwaite, Kenneth P. ;

Savoldo, Barbara ;

Ramos, Carlos A. ;

Lam, Sharon ;

Ku, Stephanie ;

Diouf, Oumar ;

Liu, Enli ;

Barrett, A. John ;

Ito, Sawa ;

Shpall, Elizabeth J. ;

Krance, Robert A. ;

Kamble, Rammurti T. ;

Carrum, George ;

Hosing, Chitra M. ;

Gee, Adrian P. ;

Mei, Zhuyong ;

Grilley, Bambi J. ;

Heslop, Helen E. ;

Rooney, Cliona M. ;

Brenner, Malcolm K. ;

Bollard, Catherine M. ;

Dotti, Gianpietro .

BLOOD, 2013, 122 (17) :2965-2973

[6] Combining CD19 Redirection and Alloanergization to Generate Tumor-Specific Human T Cells for Allogeneic Cell Therapy of B-Cell Malignancies [J].

Davies, Jeff K. ;

Singh, Harjeet ;

Huls, Helen ;

Yuk, Dongin ;

Lee, Dean A. ;

Kebriaei, Partow ;

Champlin, Richard E. ;

Nadler, Lee M. ;

Guinan, Eva C. ;

Cooper, Laurence J. N. .

CANCER RESEARCH, 2010, 70 (10) :3915-3924

[7] Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia [J].

Davila, Marco L. ;

Riviere, Isabelle ;

Wang, Xiuyan ;

Bartido, Shirley ;

Park, Jae ;

Curran, Kevin ;

Chung, Stephen S. ;

Stefanski, Jolanta ;

Borquez-Ojeda, Oriana ;

Olszewska, Malgorzata ;

Qu, Jinrong ;

Wasielewska, Teresa ;

He, Qing ;

Fink, Mitsu ;

Shinglot, Himaly ;

Youssif, Maher ;

Satter, Mark ;

Wang, Yongzeng ;

Hosey, James ;

Quintanilla, Hilda ;

Halton, Elizabeth ;

Bernal, Yvette ;

Bouhassira, Diana C. G. ;

Arcila, Maria E. ;

Gonen, Mithat ;

Roboz, Gail J. ;

Maslak, Peter ;

Douer, Dan ;

Frattini, Mark G. ;

Giralt, Sergio ;

Sadelain, Michel ;

Brentjens, Renier .

SCIENCE TRANSLATIONAL MEDICINE, 2014, 6 (224)

[8] Human CD62L- memory T cells are less responsive to alloantigen stimulation than CD62L+ naive T cells:: potential for adoptive immunotherapy and allodepletion [J].

Foster, AE ;

Marangolo, M ;

Sartor, MM ;

Alexander, SI ;

Hu, M ;

Bradstock, KF ;

Gottlieb, DJ .

BLOOD, 2004, 104 (08) :2403-2409

[9] Graft-versus-host disease after donor leukocyte infusions: presentation and management [J].

Frey, Noelle V. ;

Porter, David L. .

BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2008, 21 (02) :205-222

[10] Alternative transplant donor sources: is there any consensus? [J].

Fuchs, Ephraim ;

O'Donnell, Paul V. ;

Brunstein, Claudio G. .

CURRENT OPINION IN ONCOLOGY, 2013, 25 (02) :173-179

← 1 2 3 4 →